Search research articles
Contact Us
Filters
Showing results (761-770 of 789) with videos related to
Page
of 79
Sort By:
International Journal of Obesity Supplements
|
May 7, 2016
Are participant characteristics from ISCOLE study sites comparable to the rest of their country?
A G LeBlanc, P T Katzmarzyk, T V Barreira, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor
John P Duffy, Edmund M Harrington, Francesco G Salituro, et al.
Human Genomics
|
June 2, 2023
Modeling the longitudinal changes of ancestry diversity in the Million Veteran Program
Frank R Wendt, Gita A Pathak, Jacqueline Vahey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction
Mojun Zhu, Chunhua Chen, Nathan R Foster, et al.
The New England Journal of Medicine
|
March 5, 2020
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
Susan Swindells, Jaime-Federico Andrade-Villanueva, Gary J Richmond, et al.
Blood Advances
|
February 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study
Amy E DeZern, Nancy Gillis, Michael Otterstatter, et al.
Human Molecular Genetics
|
May 14, 2025
Unraveling the genetics of gulf war illness in diverse participants enrolled in the million veteran program
Gita A Pathak, Dora Koller, Brenda Cabrera-Mendoza, et al.
Journal of Neuroinflammation
|
June 24, 2026
Bortezomib-induced gastrointestinal dysfunction, peripheral neuropathy and neuroimmune signalling are influenced by the gut microbiota in mice
Jacqui S Scott, Sadia Munir, Miriam A Lynn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 13, 2025
Epidemiology of Healthcare Facility-Associated Nontuberculous Mycobacteria From 2012 Through 2020 in a 10-Hospital Network in the United States
Arthur W Baker, Ricardo M La Hoz, Judith A Anesi, et al.
Nature Communications
|
February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Tina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
Page
of 79
Search research articles
Search
Showing results (761-770 of 789) with videos related to
Sort By:
Page
of 79
International Journal of Obesity Supplements
|
May 7, 2016
Are participant characteristics from ISCOLE study sites comparable to the rest of their country?
A G LeBlanc, P T Katzmarzyk, T V Barreira, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor
John P Duffy, Edmund M Harrington, Francesco G Salituro, et al.
Human Genomics
|
June 2, 2023
Modeling the longitudinal changes of ancestry diversity in the Million Veteran Program
Frank R Wendt, Gita A Pathak, Jacqueline Vahey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction
Mojun Zhu, Chunhua Chen, Nathan R Foster, et al.
The New England Journal of Medicine
|
March 5, 2020
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
Susan Swindells, Jaime-Federico Andrade-Villanueva, Gary J Richmond, et al.
Blood Advances
|
February 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study
Amy E DeZern, Nancy Gillis, Michael Otterstatter, et al.
Human Molecular Genetics
|
May 14, 2025
Unraveling the genetics of gulf war illness in diverse participants enrolled in the million veteran program
Gita A Pathak, Dora Koller, Brenda Cabrera-Mendoza, et al.
Journal of Neuroinflammation
|
June 24, 2026
Bortezomib-induced gastrointestinal dysfunction, peripheral neuropathy and neuroimmune signalling are influenced by the gut microbiota in mice
Jacqui S Scott, Sadia Munir, Miriam A Lynn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 13, 2025
Epidemiology of Healthcare Facility-Associated Nontuberculous Mycobacteria From 2012 Through 2020 in a 10-Hospital Network in the United States
Arthur W Baker, Ricardo M La Hoz, Judith A Anesi, et al.
Nature Communications
|
February 16, 2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Tina J Hieken, Garth D Nelson, Thomas J Flotte, et al.
Page
of 79